Publication | Open Access
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
229
Citations
29
References
2013
Year
Double-blind Phase 3UrologyGenitourinary CancerMedicineClinical TrialsPharmacotherapyCancer TreatmentProstatic DiseaseOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1